Cargando…

Signature of prognostic epithelial–mesenchymal transition related long noncoding RNAs (ERLs) in hepatocellular carcinoma

Reliable biomarkers are of great significance for the treatment and diagnosis of hepatocellular carcinoma (HCC). This study identified potential prognostic epithelial–mesenchymal transition related lncRNAs (ERLs) by the cancer genome atlas (TCGA) database and bioinformatics. The differential express...

Descripción completa

Detalles Bibliográficos
Autores principales: Xu, Bang-Hao, Jiang, Jing-Hang, Luo, Tao, Jiang, Zhi-Jun, Liu, Xin-Yu, Li, Le-Qun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8322489/
https://www.ncbi.nlm.nih.gov/pubmed/34397721
http://dx.doi.org/10.1097/MD.0000000000026762
_version_ 1783731059082395648
author Xu, Bang-Hao
Jiang, Jing-Hang
Luo, Tao
Jiang, Zhi-Jun
Liu, Xin-Yu
Li, Le-Qun
author_facet Xu, Bang-Hao
Jiang, Jing-Hang
Luo, Tao
Jiang, Zhi-Jun
Liu, Xin-Yu
Li, Le-Qun
author_sort Xu, Bang-Hao
collection PubMed
description Reliable biomarkers are of great significance for the treatment and diagnosis of hepatocellular carcinoma (HCC). This study identified potential prognostic epithelial–mesenchymal transition related lncRNAs (ERLs) by the cancer genome atlas (TCGA) database and bioinformatics. The differential expression of long noncoding RNA (lncRNA) was obtained by analyzing the lncRNA data of 370 HCC samples in TCGA. Then, Pearson correlation analysis was carried out with EMT related genes (ERGs) from molecular signatures database. Combined with the univariate Cox expression analysis of the total survival rate of hepatocellular carcinoma (HCC) patients, the prognostic ERLs were obtained. Then use “step” function to select the optimal combination of constructing multivariate Cox expression model. The expression levels of ERLs in HCC samples were verified by real-time quantitative polymerase chain reaction. Finally, we identified 5 prognostic ERLs (AC023157.3, AC099850.3, AL031985.3, AL365203.2, CYTOR). The model showed that these prognostic markers were reliable independent predictors of risk factors (P value <.0001, hazard ratio [HR] = 2.400, 95% confidence interval [CI] = 1.667–3.454 for OS). In the time-dependent receiver operating characteristic analysis, this prognostic marker is a good predictor of HCC survival (area under the curve of 1 year, 2 years, 3 years, and 5 years are 0.754, 0.720, 0.704, and 0.662 respectively). We analyzed the correlation of clinical characteristics of these prognostic markers, and the results show that this prognostic marker is an independent factor that can predict the prognosis of HCC more accurately. In addition, by matching with the Molecular Signatures Database, we obtained 18 ERLs, and then constructed the HCC prognosis model and clinical feature correlation analysis using 5 prognostic ERLs. The results show that these prognostic markers have reliable independent predictive value. Bioinformatics analysis showed that these prognostic markers were involved in the regulation of EMT and related functions of tumor occurrence and migration. Five prognostic types of ERLs identified in this study can be used as potential biomarkers to predict the prognosis of HCC.
format Online
Article
Text
id pubmed-8322489
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-83224892021-08-02 Signature of prognostic epithelial–mesenchymal transition related long noncoding RNAs (ERLs) in hepatocellular carcinoma Xu, Bang-Hao Jiang, Jing-Hang Luo, Tao Jiang, Zhi-Jun Liu, Xin-Yu Li, Le-Qun Medicine (Baltimore) 7100 Reliable biomarkers are of great significance for the treatment and diagnosis of hepatocellular carcinoma (HCC). This study identified potential prognostic epithelial–mesenchymal transition related lncRNAs (ERLs) by the cancer genome atlas (TCGA) database and bioinformatics. The differential expression of long noncoding RNA (lncRNA) was obtained by analyzing the lncRNA data of 370 HCC samples in TCGA. Then, Pearson correlation analysis was carried out with EMT related genes (ERGs) from molecular signatures database. Combined with the univariate Cox expression analysis of the total survival rate of hepatocellular carcinoma (HCC) patients, the prognostic ERLs were obtained. Then use “step” function to select the optimal combination of constructing multivariate Cox expression model. The expression levels of ERLs in HCC samples were verified by real-time quantitative polymerase chain reaction. Finally, we identified 5 prognostic ERLs (AC023157.3, AC099850.3, AL031985.3, AL365203.2, CYTOR). The model showed that these prognostic markers were reliable independent predictors of risk factors (P value <.0001, hazard ratio [HR] = 2.400, 95% confidence interval [CI] = 1.667–3.454 for OS). In the time-dependent receiver operating characteristic analysis, this prognostic marker is a good predictor of HCC survival (area under the curve of 1 year, 2 years, 3 years, and 5 years are 0.754, 0.720, 0.704, and 0.662 respectively). We analyzed the correlation of clinical characteristics of these prognostic markers, and the results show that this prognostic marker is an independent factor that can predict the prognosis of HCC more accurately. In addition, by matching with the Molecular Signatures Database, we obtained 18 ERLs, and then constructed the HCC prognosis model and clinical feature correlation analysis using 5 prognostic ERLs. The results show that these prognostic markers have reliable independent predictive value. Bioinformatics analysis showed that these prognostic markers were involved in the regulation of EMT and related functions of tumor occurrence and migration. Five prognostic types of ERLs identified in this study can be used as potential biomarkers to predict the prognosis of HCC. Lippincott Williams & Wilkins 2021-07-30 /pmc/articles/PMC8322489/ /pubmed/34397721 http://dx.doi.org/10.1097/MD.0000000000026762 Text en Copyright © 2021 the Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution-Non Commercial License 4.0 (CCBY-NC), where it is permissible to download, share, remix, transform, and buildup the work provided it is properly cited. The work cannot be used commercially without permission from the journal. http://creativecommons.org/licenses/by-nc/4.0 (https://creativecommons.org/licenses/by-nc/4.0/)
spellingShingle 7100
Xu, Bang-Hao
Jiang, Jing-Hang
Luo, Tao
Jiang, Zhi-Jun
Liu, Xin-Yu
Li, Le-Qun
Signature of prognostic epithelial–mesenchymal transition related long noncoding RNAs (ERLs) in hepatocellular carcinoma
title Signature of prognostic epithelial–mesenchymal transition related long noncoding RNAs (ERLs) in hepatocellular carcinoma
title_full Signature of prognostic epithelial–mesenchymal transition related long noncoding RNAs (ERLs) in hepatocellular carcinoma
title_fullStr Signature of prognostic epithelial–mesenchymal transition related long noncoding RNAs (ERLs) in hepatocellular carcinoma
title_full_unstemmed Signature of prognostic epithelial–mesenchymal transition related long noncoding RNAs (ERLs) in hepatocellular carcinoma
title_short Signature of prognostic epithelial–mesenchymal transition related long noncoding RNAs (ERLs) in hepatocellular carcinoma
title_sort signature of prognostic epithelial–mesenchymal transition related long noncoding rnas (erls) in hepatocellular carcinoma
topic 7100
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8322489/
https://www.ncbi.nlm.nih.gov/pubmed/34397721
http://dx.doi.org/10.1097/MD.0000000000026762
work_keys_str_mv AT xubanghao signatureofprognosticepithelialmesenchymaltransitionrelatedlongnoncodingrnaserlsinhepatocellularcarcinoma
AT jiangjinghang signatureofprognosticepithelialmesenchymaltransitionrelatedlongnoncodingrnaserlsinhepatocellularcarcinoma
AT luotao signatureofprognosticepithelialmesenchymaltransitionrelatedlongnoncodingrnaserlsinhepatocellularcarcinoma
AT jiangzhijun signatureofprognosticepithelialmesenchymaltransitionrelatedlongnoncodingrnaserlsinhepatocellularcarcinoma
AT liuxinyu signatureofprognosticepithelialmesenchymaltransitionrelatedlongnoncodingrnaserlsinhepatocellularcarcinoma
AT lilequn signatureofprognosticepithelialmesenchymaltransitionrelatedlongnoncodingrnaserlsinhepatocellularcarcinoma